Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Staurosporine derivatives as inhibitors of FLT3 receptor tyrosine kinase activity

Staurosporine derivatives as inhibitors of FLT3 receptor tyrosine kinase activity

US Patent 8445479 · Granted May 21, 2013

Estimated economic value: $8,675,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Compositions and methods for identification, assessment, prevention, and treatme2021
Methods of predicting resistance to JAK inhibitor therapy2018
Benzamide derivatives for inhibiting the activity of ABL1, ABL2 and BCR-ABL12018
Method of treating mixed lineage leukemia gene-rearranged acute lymphoblastic le2017
Compounds and compositions for inhibiting the activity of ABL1, ABL2 and BCR-ABL2016
Benzamide derivatives for inhibiting the activity of ABL1, ABL2 and BCR-ABL12016
Compounds and compositions for inhibiting the activity of ABL1, ABL2 and BCR-ABL2016
Compounds and compositions for inhibiting the activity of ABL1, ABL2 and BCR-ABL2016
Salts of 4-methyl-N-[3-(4-methyl-imidazol-1-yl)-5-trifluoromethyl-phenyl]-3-(4-p2015
Crystalline forms of 4-methyl-N-[3-(4-methyl-imidazol-1-yl)-5-trifluoromethyl-ph2014
Compounds and compositions for inhibiting the activity of ABL1, ABL2 and BCR-ABL2014
Pyrimidylaminobenzamide derivatives for systemic mastocytosis2014